Refine search

Date
Tumour Site
Topics
Congress

678 results for ""

Editorial_PrecisionMedicine

Precision oncology – are we at an inflection point?

At Molecular Analysis for Precision Oncology (MAP) Congress 2023, international experts discuss the future of histology-agnostic drug development and clinical trial design

    By
  • Benedikt Westphalen
One Health
Cancer Control Principles

Extreme weather, extreme problems in oncology

This summer, photos of New York covered by smoke spread widely catching global attention on the massive wildfires in Canadian forests that caused that apocalyptic scenario. But why should we as oncologists be concerned about such events?

By Pawel Sobczuk
A growing community

A growing community

Teresa Del Giudice is the 30,000th ESMO Member. In this interview she explains what motivated her to join the community.

On Target
Cancer Research

On the horizon of translational research

Tumour agnostic targeted agents and ‘smarter’ dynamic designs are two major areas of interest leading to more patient-centric approaches in cancer care

By Elena Garralda

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.